Literature DB >> 12183432

The T-lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells.

David Grimwade1, Susan V Outram, Rajinder Flora, Stuart J Ings, Arnold R Pizzey, Ricardo Morilla, Charles F Craddock, David C Linch, Ellen Solomon.   

Abstract

The nature of hemopoietic progenitors subject to leukemic transformation in acute myeloid leukemia (AML) has not been clearly defined. To address this issue, we have used DNase I hypersensitivity assays to study the chromatin structure surrounding the T-lineage-affiliated CD2 gene in the acute promyelocytic subtype of AML (APL). Upstream and downstream flanking regions of CD2 were found to be hypersensitive to DNase I in primary APL blasts, with an identical pattern of hypersensitive sites to those detected in cells of T-lineage. All of the sites were confirmed to be inaccessible to DNase I in B-lineage leukemia cells. The demonstration of T-cell-associated chromatin features in primary APL blasts has implications for the origin of APL that may arise in more primitive progenitors than previously considered to be the case.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183432

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  CD2+ tetraploid acute promyelocytic leukemia variant with double (15;17) translocations.

Authors:  Ken Kaito; Hiroko Otsubo; Nobuaki Dobashi; Noriko Usui; Masayuki Kobayashi
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

2.  CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900.

Authors:  Mithat Gönen; Zhuoxin Sun; Maria E Figueroa; Jay P Patel; Omar Abdel-Wahab; Janis Racevskis; Rhett P Ketterling; Hugo Fernandez; Jacob M Rowe; Martin S Tallman; Ari Melnick; Ross L Levine; Elisabeth Paietta
Journal:  Blood       Date:  2012-08-01       Impact factor: 22.113

3.  Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease.

Authors:  Emma Hockly; Victoria M Richon; Benjamin Woodman; Donna L Smith; Xianbo Zhou; Eddie Rosa; Kirupa Sathasivam; Shabnam Ghazi-Noori; Amarbirpal Mahal; Philip A S Lowden; Joan S Steffan; J Lawrence Marsh; Leslie M Thompson; Cathryn M Lewis; Paul A Marks; Gillian P Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

4.  FLT3/ITD associated with an immature immunophenotype in PML-RARα leukemia.

Authors:  Mariko Takenokuchi; Seiji Kawano; Yuji Nakamachi; Yasuyuki Sakota; Meilani Syampurnawati; Katsuyasu Saigo; Eiji Tatsumi; Shunichi Kumagai
Journal:  Hematol Rep       Date:  2012-10-16

5.  Early mortality in acute promyelocytic leukemia: Potential predictors.

Authors:  Can Chen; Xilian Huang; Kaile Wang; Kuang Chen; Danquan Gao; Shenxian Qian
Journal:  Oncol Lett       Date:  2018-01-24       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.